Committee Recommends Adding More Patients To Amryt Pharma's Ease Trial
LONDON (Alliance News) - Amryt Pharma PLC on Friday said an independent data monitoring committee has recommended adding more patients to its phase three Ease trial of epidermolysis bullosa drug a Read More